Leading a Mandated Antimicrobial Stewardship Rollout With Skeptical Staff
You are the newly appointed pharmacy manager of a 25-pharmacist department. The health system has mandated implementation of a pharmacist-driven antimicrobial stewardship audit and feedback program in 90 days. Two senior pharmacists are openly skeptical, saying previous initiatives 'died on the vine' and that they are too understaffed. The department has no dedicated stewardship FTE, but the infectious diseases physician is supportive. Baseline data show broad-spectrum antibiotic use is 20% above the system benchmark and that pharmacist interventions are documented in free text rather than a structured tool. Staff satisfaction survey scores are low (2.8/5) for 'voice in decisions.'
1. How would you frame the change and identify key stakeholders and early adopters?
Read the worked answer
Frame the mandate around patient safety and shared professional accountability, not compliance alone: current broad-spectrum use is 20% above benchmark, which represents avoidable resistance and Clostridioides difficile risk.
Stakeholders:
- Sponsor: hospital leadership and the ID physician champion.
- Implementers: staff pharmacists, clinical coordinators, and residents.
- Affected groups: prescribers, nursing, microbiology laboratory, and infection prevention.
- Blockers/influencers: the two senior pharmacists, whose concerns about workload and past failures are legitimate data.
Identify early adopters by asking who already performs informal stewardship and who is respected by peers. Invite the skeptics into design rather than trying to win them over with a memo. Use a structured change model such as ADKAR or Kotter: create urgency with local data, build a guiding coalition, and co-design the workflow.
2. Design a 90-day implementation and education plan with measurable milestones.
Read the worked answer
Days 1–15: Charter the team with ID, pharmacy, nursing, and lab. Define scope (for example, broad-spectrum antibiotics reviewed at 48–72 hours). Map current workflow and barriers.
Days 16–30: Build a structured documentation tool and a one-page audit form. Draft criteria for recommended interventions. Recruit two pilot units and 4–6 champion pharmacists.
Days 31–60: Deliver short, case-based education (15-minute huddles, not lengthy lectures). Pilot audit and feedback on two units. Collect baseline and weekly data. Run PDSA cycles on the feedback process.
Days 61–90: Spread to all units. Integrate documentation into the EHR or existing workflow so it does not add a separate step.
Milestones: ≥80% of pharmacists trained; ≥50 audits completed per week; ≥90% of interventions documented in structured fields; 10% reduction in broad-spectrum days of therapy; monthly feedback reports delivered to prescribers.
3. How would you address the senior pharmacists' resistance and sustain the program?
Read the worked answer
Start by listening and validating their experience: ask what caused prior initiatives to fail and what would make this one different. Their staffing concern is real, so avoid dismissing it.
Actions:
- Involve them in designing the workflow and choosing the audit criteria; this restores 'voice in decisions.'
- Reduce burden by integrating audits into existing rounds and using a short structured tool rather than free text.
- Use the ID physician champion to co-lead peer conversations with prescribers.
- Share early small wins with staff and leadership; recognize pharmacists publicly.
- Protect time by repurposing existing clinical activities rather than promising a nonexistent FTE.
- Sustain with monthly dashboards, a standing agenda item, and periodic reassessment of workload and satisfaction.
Success is not just the 90-day metric but whether staff report that the program is feasible and worth sustaining.